Diagnostic and Interventional Radiology
Cardiovascular Imaging - Original Article

Efficacy of ivabradin to reduce heart rate prior to coronary CT angiography: comparison with beta-blocker


Department of Radiology, Atatürk University, Faculty of Medicine, Erzurum, Turkey


Department of Radiology, Atatürk University Faculty of Medicine, Erzurum, Turkey


Departments of Cardiology, Atatürk University School of Medicine, Erzurum, Turkey


Departments of Radiology, Atatürk University School of Medicine, Erzurum, Turkey


Kadir Has Üniversitesi Tıp Fakültesi, Radyodiagnostik Anabilim Dalı


Departments of Cardiology, Atatürk University School of Medicine, Erzurum, Turkey


Department of Diagnostic Radiology, University of Pamukkale, Denizli, Turkey

Diagn Interv Radiol 2012; 18: 537-541
DOI: 10.4261/1305-3825.DIR.5981-12.1
Read: 1263 Downloads: 854 Published: 03 September 2019


PURPOSE The objective of our study was to assess the effect of ivabradine on image quality of ECG-gated multidetector computed tomography (MDCT) coronary angiography. 


Computed tomography coronary angiography (CTCA) was performed on two groups. In Group 1 (n=54), an intravenous beta-blocker was administered to patients with a heart rate >70 beats per minute (bpm) just before CTCA. In Group 2 (n=56), oral ivabradine 5 mg was administered twice a day for three days prior to CTCA examination to patients with a heart rate >70 bpm and contraindication to beta-blockers. Images acquired on two different MDCT scanners were scored in terms of image quality of the coronary artery segments using a 5-point grading scale (Grade 1, unreadable; Grade 5, excellent). 


The mean heart rates during CTCA were 64±6.7 bpm for Group 1 and 59±4.1 bpm for Group 2 (P < 0.05). Mean heart rate reduction was 9±5% and 14±8% for Groups 1 and 2, respectively (P < 0.001). A total of 880 segments were evaluated in 110 patients. When the best reconstruction interval was used, 89.8% and 95.5% of all the coronary segments showed acceptable image quality in Groups 1 and 2, respectively. Acceptable image quality of the middle right coronary artery was obtained in 78.3% of Group 1 and 92.4% of Group 2. These ratios for the other segments were 88.4% for Group 1 and 95.2% for Group 2. 


Reduction of heart rates with ivabradine premedication improves the image quality of CTCA. It should be considered as an alternative drug, particularly in patients with contraindications to beta-blockers.

EISSN 1305-3612